BioSpace News Archive

Business

Myovant Sciences to Host First Fiscal Quarter 2021 Earnings Conference Call at 8:30 a.m. Eastern Time on July 28, 2021

Myovant Sciences (NYSE: MYOV), a healthcare company focused on redefining care for women and for men, today announced it will host a webcast and conference call to discuss corporate updates and financial results for its first fiscal quarter 2021, ended June 30, 2021.

July 14, 2021
·
2 min read
Business

City of Hope and Osel Announce Exclusive License for Intellectual Property on the Use of Live Biotherapeutic Product CBM588 for Oncology Therapeutic Applications

City of Hope and Osel, Inc. today announced that City of Hope has granted an exclusive worldwide license to Osel for intellectual property on the novel use of a LBP CBM588 to enhance efficacy of checkpoint inhibitors to treat cancer, including metastatic renal cell carcinoma.

July 14, 2021
·
4 min read
Drug Development

Jaguar Health Announces Completion of Investigator-Initiated Phase 2 HALT-D Study Evaluating Mytesi (Crofelemer) for Prevention and Prophylaxis of Diarrhea in Breast Cancer Patients

Jaguar Health, Inc. (NASDAQ:JAGX) today announced that the third-party, investigator-initiated Phase 2 HALT-D study evaluating the effectiveness of Mytesi (crofelemer) for symptomatic relief of diarrhea in HER2 positive breast cancer.

July 14, 2021
·
5 min read
Business

Over 26 Million Women Have Uterine Fibroids

It’s hard to imagine losing your ability to have children when you’re only 30-years-old. But for women who suffer from uterine fibroids, that could be the reality if their doctor recommends they undergo a hysterectomy.

July 14, 2021
·
2 min read
Bio NC

Kepley BioSystems Awarded National Science Foundation Grant to Help Prevent the Leading Cause of Untimely Death, Sepsis

Kepley BioSystems received NSF funding to develop a disruptive innovation and global healthcare solution to combat sepsis.

July 14, 2021
·
3 min read
Business

Essenlix Appoints Dieter Weinand, Former Bayer, Pfizer, and Sanofi Executive, as Executive Chairman

Essenlix Corporation today announced that Dieter Weinand has joined the company as Executive Chairman of its Board of Directors.

July 14, 2021
·
3 min read
Policy

Cue Health Receives Regulatory Approval in India for its Molecular, Point-of-Care COVID-19 Test

Cue Health Inc. (“Cue Health” or “Cue”), a healthcare technology company, today announced it has received regulatory approval from The Central Drugs Standard Control Organisation (CDSCO) for the Cue COVID-19 Test for professional point-of-care use in India.

July 14, 2021
·
3 min read
Business

Shorla Pharma Expands into the U.S. with the Opening of a Cambridge, MA Office

Shorla Pharma Limited, a specialty pharmaceutical company, has announced its arrival in the United States locating a base in Boston’s innovative Cambridge biotech cluster.

July 14, 2021
·
2 min read
Business

Curebase, InBios Announce Results of Virtual Clinical Trial of InBios COVID-19 Rapid Detection Test Using Curebase Platform

Curebase today announced that InBios successfully utilized Curebase’s virtual site solution to power clinical studies for its SCoV-2 Ag Detect™ Rapid Test, which was granted Emergency Use Authorization (EUA) by the U.S. Food and Drug Administration (FDA) on May 6, 2021.

July 14, 2021
·
4 min read
Business

Ampio Pharmaceuticals, Inc. to Report Fiscal 2021 Second Quarter Financial Results and Provide Corporate Business Update

Ampio Pharmaceuticals today announced it will host a conference call to discuss financial results for the quarter ended June 30, 2021 , and provide a corporate business update on Wednesday, August 4, 2021, at 4:30 pm EDT/ 2:30 pm MT.

July 14, 2021
·
2 min read